57/100B424.54
USD
-5.65
(-1.31%)
Market Open
Last updated: · Delayed 15 min
Fair value401.93Plus+6%262Price 424.54501
Q4 FY2026 · Earnings report
EPS estimate 2.08Revenue estimate 49.38B
Q4 FY2026 · Earnings report
EPS estimate 2.08Revenue estimate 49.38B
Elevance Health total debt 1998–2026What is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Elevance Health's total debt was 30.76B USD on 30 September 2026, down 4.2% on a year before. At the end of fiscal year 2025 it was 33.24B USD.
Last updated 12 Nov 2026 · Next report 27 Jan 2027
Total debt
Growth
| Fiscal year | Period ending | Total debt | Growth | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Latest quarter | 30 Sept 2026 | 30.76B | -4.19% | 37.85B | 7.09B | 0.69 |
| FY2025 | 31 Dec 2025 | 33.24B | +1.63% | 9.49B | -23.74B | 0.76 |
| FY2024 | 31 Dec 2024 | 32.70B | +22.69% | 8.29B | -24.41B | 0.79 |
| FY2023 | 31 Dec 2023 | 26.65B | +3.32% | 6.53B | -20.13B | 0.68 |
| FY2022 | 31 Dec 2022 | 25.80B | +3.64% | 7.39B | -18.41B | 0.71 |
| FY2021 | 31 Dec 2021 | 24.89B | +13.98% | 4.88B | -20.01B | 0.69 |
| FY2020 | 31 Dec 2020 | 21.84B | +2.98% | 5.74B | -16.10B | 0.66 |
| FY2019 | 31 Dec 2019 | 21.21B | +10.39% | 4.94B | -16.27B | 0.67 |
| FY2018 | 31 Dec 2018 | 19.21B | -3.62% | 3.93B | -15.28B | 0.67 |
| FY2017 | 31 Dec 2017 | 19.93B | +26.74% | 3.61B | -16.32B | 0.75 |
| FY2016 | 31 Dec 2016 | 15.73B | -0.87% | 4.08B | -11.65B | 0.63 |
| FY2015 | 31 Dec 2015 | 15.86B | +5.45% | 2.11B | -13.75B | 0.69 |
| FY2014 | 31 Dec 2014 | 15.04B | +3.81% | 2.15B | -12.89B | 0.62 |
| FY2013 | 31 Dec 2013 | 14.49B | -3.25% | 1.58B | -12.91B | 0.59 |
| FY2012 | 31 Dec 2012 | 14.98B | +52.21% | 2.48B | -12.50B | 0.63 |
| FY2011 | 31 Dec 2011 | 9.84B | +9.90% | 2.20B | -7.64B | 0.42 |
| FY2010 | 31 Dec 2010 | 8.95B | +6.60% | 1.79B | -7.16B | 0.38 |
| FY2009 | 31 Dec 2009 | 8.40B | -5.00% | 4.82B | -3.58B | 0.34 |
| FY2008 | 31 Dec 2008 | 8.84B | -2.24% | 2.18B | -6.66B | 0.41 |
| FY2007 | 31 Dec 2007 | 9.04B | +28.94% | 2.77B | -6.28B | 0.39 |
| FY2006 | 31 Dec 2006 | 7.01B | +3.06% | 2.60B | -4.41B | 0.29 |
| FY2005 | 31 Dec 2005 | 6.81B | +53.74% | 2.74B | -4.07B | 0.27 |
| FY2004 | 31 Dec 2004 | 4.43B | +114.43% | 1.46B | -2.97B | 0.23 |
| FY2003 | 31 Dec 2003 | 2.06B | +24.41% | 7.38B | 5.32B | 0.34 |
| FY2002 | 31 Dec 2002 | 1.66B | +47.02% | 6.64B | 4.98B | 0.31 |
| FY2001 | 31 Dec 2001 | 1.13B | +88.90% | 4.48B | 3.35B | 0.55 |
| FY2000 | 31 Dec 2000 | 597.50M | +14.46% | 0.00 | -597.50M | 0.31 |
| FY1999 | 31 Dec 1999 | 522.00M | +72.90% | 0.00 | -522.00M | 0.31 |
| FY1998 | 31 Dec 1998 | 301.90M | — | 0.00 | -301.90M | 0.18 |
| Quarter | Period ending | Total debt | Growth on a year before | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 30.76B | -4.19% | 37.85B | 7.09B | 0.69 |
| Q2 FY2026 | 30 Jun 2026 | 31.04B | +2.84% | 37.51B | 6.47B | 0.69 |
| Q1 FY2026 | 31 Mar 2026 | 31.84B | +6.13% | 35.56B | 3.72B | 0.73 |
| Q4 FY2025 | 31 Dec 2025 | 33.24B | +1.63% | 9.49B | -23.74B | 0.76 |
| Q3 FY2025 | 30 Sept 2025 | 32.10B | +18.25% | 8.71B | -23.39B | 0.73 |
| Q2 FY2025 | 30 Jun 2025 | 30.19B | +9.03% | 8.56B | -21.63B | 0.69 |
| Q1 FY2025 | 31 Mar 2025 | 30.00B | +13.43% | 7.50B | -22.50B | 0.71 |
| Q4 FY2024 | 31 Dec 2024 | 32.70B | +22.69% | 8.29B | -24.41B | 0.79 |
| Q3 FY2024 | 30 Sept 2024 | 27.15B | +2.81% | 7.87B | -19.28B | 0.62 |
| Q2 FY2024 | 30 Jun 2024 | 27.69B | +3.55% | 6.50B | -21.19B | 0.66 |
| Q1 FY2024 | 31 Mar 2024 | 26.45B | -2.39% | 6.23B | -20.23B | 0.65 |
| Q4 FY2023 | 31 Dec 2023 | 26.65B | +3.32% | 6.53B | -20.13B | 0.68 |
| Q3 FY2023 | 30 Sept 2023 | 26.41B | +3.83% | 10.92B | -15.49B | 0.69 |
| Q2 FY2023 | 30 Jun 2023 | 26.74B | +5.91% | 9.99B | -16.75B | 0.70 |
| Q1 FY2023 | 31 Mar 2023 | 27.10B | +8.41% | 10.14B | -16.96B | 0.73 |
| Q4 FY2022 | 31 Dec 2022 | 25.80B | +3.64% | 7.39B | -18.41B | 0.71 |
| Q3 FY2022 | 30 Sept 2022 | 25.43B | +3.64% | 8.87B | -16.56B | 0.71 |
| Q2 FY2022 | 30 Jun 2022 | 25.24B | +0.77% | 6.46B | -18.79B | 0.70 |
| Q1 FY2022 | 31 Mar 2022 | 25.00B | +0.18% | 6.16B | -18.84B | 0.69 |
| Q4 FY2021 | 31 Dec 2021 | 24.89B | +13.98% | 4.88B | -20.01B | 0.69 |
| Q3 FY2021 | 30 Sept 2021 | 24.54B | +8.43% | 5.49B | -19.05B | 0.69 |
| Q2 FY2021 | 30 Jun 2021 | 25.05B | +7.52% | 5.26B | -19.79B | 0.72 |
| Q1 FY2021 | 31 Mar 2021 | 24.95B | +6.27% | 9.33B | -15.63B | 0.74 |
| Q4 FY2020 | 31 Dec 2020 | 21.84B | +2.98% | 5.74B | -16.10B | 0.66 |
| Q3 FY2020 | 30 Sept 2020 | 22.63B | +6.03% | 3.98B | -18.65B | 0.67 |
| Q2 FY2020 | 30 Jun 2020 | 23.30B | +13.55% | 6.03B | -17.27B | 0.68 |
| Q1 FY2020 | 31 Mar 2020 | 23.48B | +14.23% | 5.35B | -18.14B | 0.74 |
| Q4 FY2019 | 31 Dec 2019 | 21.21B | +10.39% | 4.94B | -16.27B | 0.67 |
| Q3 FY2019 | 30 Sept 2019 | 21.34B | +9.91% | 4.19B | -17.15B | 0.68 |
| Q2 FY2019 | 30 Jun 2019 | 20.52B | +6.40% | 4.08B | -16.44B | 0.67 |
| Q1 FY2019 | 31 Mar 2019 | 20.56B | +3.36% | 4.48B | -16.07B | 0.69 |
| Q4 FY2018 | 31 Dec 2018 | 19.21B | -3.62% | 3.93B | -15.28B | 0.67 |
| Q3 FY2018 | 30 Sept 2018 | 19.42B | +19.64% | 4.26B | -15.16B | 0.67 |
| Q2 FY2018 | 30 Jun 2018 | 19.29B | +18.37% | 4.68B | -14.60B | 0.67 |
| Q1 FY2018 | 31 Mar 2018 | 19.89B | +16.00% | 4.63B | -15.26B | 0.74 |
| Q4 FY2017 | 31 Dec 2017 | 19.93B | +26.74% | 3.61B | -16.32B | 0.75 |
| Q3 FY2017 | 30 Sept 2017 | 16.23B | +3.97% | 6.10B | -10.13B | 0.63 |
| Q2 FY2017 | 30 Jun 2017 | 16.29B | +4.64% | 4.56B | -11.73B | 0.62 |
| Q1 FY2017 | 31 Mar 2017 | 17.14B | +8.47% | 6.77B | -10.37B | 0.66 |
| Q4 FY2016 | 31 Dec 2016 | 15.73B | -0.87% | 22.72B | 7.00B | 0.63 |
| Q3 FY2016 | 30 Sept 2016 | 15.61B | -3.99% | 22.26B | 6.65B | 0.63 |
| Q2 FY2016 | 30 Jun 2016 | 15.57B | -6.39% | 20.16B | 4.59B | 0.64 |
| Q1 FY2016 | 31 Mar 2016 | 15.80B | -0.23% | 20.05B | 4.25B | 0.67 |
| Q4 FY2015 | 31 Dec 2015 | 15.86B | +5.45% | 19.05B | 3.19B | 0.69 |
| Q3 FY2015 | 30 Sept 2015 | 16.26B | +6.53% | 19.46B | 3.20B | 0.70 |
| Q2 FY2015 | 30 Jun 2015 | 16.63B | +12.41% | 19.81B | 3.18B | 0.72 |
| Q1 FY2015 | 31 Mar 2015 | 15.84B | +5.31% | 20.23B | 4.39B | 0.65 |
| Q4 FY2014 | 31 Dec 2014 | 15.04B | +3.81% | 19.64B | 4.60B | 0.62 |
| Q3 FY2014 | 30 Sept 2014 | 15.26B | +2.69% | 20.02B | 4.76B | 0.63 |
| Q2 FY2014 | 30 Jun 2014 | 14.80B | -0.30% | 20.14B | 5.34B | 0.61 |
| Q1 FY2014 | 31 Mar 2014 | 15.04B | +1.77% | 20.00B | 4.96B | 0.62 |
| Q4 FY2013 | 31 Dec 2013 | 14.49B | -3.25% | 18.64B | 4.15B | 0.59 |
| Q3 FY2013 | 30 Sept 2013 | 14.86B | +9.39% | 19.74B | 4.87B | 0.60 |
| Q2 FY2013 | 30 Jun 2013 | 14.84B | +33.11% | 19.04B | 4.20B | 0.60 |
| Q1 FY2013 | 31 Mar 2013 | 14.78B | +56.01% | 19.50B | 4.72B | 0.61 |
| Q4 FY2012 | 31 Dec 2012 | 14.98B | +52.21% | 19.40B | 4.43B | 0.63 |
| Q3 FY2012 | 30 Sept 2012 | 13.59B | +35.93% | 22.13B | 8.54B | 0.57 |
| Q2 FY2012 | 30 Jun 2012 | 11.15B | +26.00% | 20.31B | 9.17B | 0.47 |
| Q1 FY2012 | 31 Mar 2012 | 9.47B | +5.24% | 19.72B | 10.25B | 0.40 |
| Q4 FY2011 | 31 Dec 2011 | 9.84B | +9.90% | 18.13B | 8.29B | 0.42 |
| Q3 FY2011 | 30 Sept 2011 | 10.00B | +10.78% | 20.17B | 10.17B | 0.42 |
| Q2 FY2011 | 30 Jun 2011 | 8.85B | +3.51% | 19.56B | 10.71B | 0.37 |
| Q1 FY2011 | 31 Mar 2011 | 9.00B | +7.28% | 19.54B | 10.54B | 0.38 |
| Q4 FY2010 | 31 Dec 2010 | 8.95B | +6.60% | 19.12B | 10.16B | 0.38 |
| Q3 FY2010 | 30 Sept 2010 | 9.02B | +1.82% | 2.25B | -6.78B | 0.37 |
| Q2 FY2010 | 30 Jun 2010 | 8.55B | -6.79% | 2.03B | -6.52B | 0.36 |
| Q1 FY2010 | 31 Mar 2010 | 8.39B | -10.15% | 3.53B | -4.86B | 0.34 |
| Q4 FY2009 | 31 Dec 2009 | 8.40B | -5.00% | 21.55B | 13.15B | 0.34 |
| Q3 FY2009 | 30 Sept 2009 | 8.86B | -3.83% | 1.84B | -7.02B | 0.39 |
| Q2 FY2009 | 30 Jun 2009 | 9.17B | -6.12% | 1.72B | -7.45B | 0.41 |
| Q1 FY2009 | 31 Mar 2009 | 9.34B | +0.55% | 2.38B | -6.96B | 0.43 |
| Q4 FY2008 | 31 Dec 2008 | 8.84B | -2.24% | 2.18B | -6.66B | 0.41 |
| Q3 FY2008 | 30 Sept 2008 | 9.22B | +5.89% | 2.27B | -6.94B | 0.43 |
| Q2 FY2008 | 30 Jun 2008 | 9.77B | +19.54% | 5.82B | -3.95B | 0.46 |
| Q1 FY2008 | 31 Mar 2008 | 9.29B | +30.67% | 6.36B | -2.92B | 0.43 |
| Q4 FY2007 | 31 Dec 2007 | 9.04B | +28.94% | 6.49B | -2.55B | 0.39 |
| Q3 FY2007 | 30 Sept 2007 | 8.70B | +18.50% | 6.75B | -1.95B | 0.37 |
| Q2 FY2007 | 30 Jun 2007 | 8.17B | +9.42% | 7.98B | -193.30M | 0.33 |
| Q1 FY2007 | 31 Mar 2007 | 7.11B | -0.47% | 7.13B | 27.20M | 0.28 |
| Q4 FY2006 | 31 Dec 2006 | 7.01B | +3.06% | 5.05B | -1.96B | 0.29 |
| Q3 FY2006 | 30 Sept 2006 | 7.34B | +67.75% | 4.50B | -2.84B | 0.30 |
| Q2 FY2006 | 30 Jun 2006 | 7.47B | +61.57% | 3.92B | -3.55B | 0.32 |
| Q1 FY2006 | 31 Mar 2006 | 7.14B | +67.09% | 4.24B | -2.91B | 0.30 |
| Q4 FY2005 | 31 Dec 2005 | 6.81B | +59.14% | 19.52B | 12.71B | 0.27 |
| Q3 FY2005 | 30 Sept 2005 | 4.38B | +130.53% | 16.74B | 12.37B | 0.21 |
| Q2 FY2005 | 30 Jun 2005 | 4.62B | +120.83% | 16.62B | 11.99B | 0.22 |
| Q1 FY2005 | 31 Mar 2005 | 4.27B | +106.21% | 15.77B | 11.49B | 0.21 |
| Q4 FY2004 | 31 Dec 2004 | 4.28B | +107.15% | 15.04B | 10.77B | 0.22 |
| Q3 FY2004 | 30 Sept 2004 | 1.90B | -9.97% | 7.95B | 6.05B | 0.28 |
| Q2 FY2004 | 30 Jun 2004 | 2.09B | +2.73% | 7.53B | 5.44B | 0.32 |
| Q1 FY2004 | 31 Mar 2004 | 2.07B | +1.37% | 7.86B | 5.79B | 0.33 |
| Q4 FY2003 | 31 Dec 2003 | 2.06B | +24.41% | 7.38B | 5.32B | 0.34 |
| Q3 FY2003 | 30 Sept 2003 | 2.11B | +3.92% | 7.18B | 5.07B | 0.36 |
| Q2 FY2003 | 30 Jun 2003 | 2.04B | +81.27% | 7.15B | 5.11B | 0.36 |
| Q1 FY2003 | 31 Mar 2003 | 2.04B | +73.40% | 6.86B | 4.81B | 0.37 |
| Q4 FY2002 | 31 Dec 2002 | 1.66B | +47.02% | 6.64B | 4.98B | 0.31 |
| Q3 FY2002 | 30 Sept 2002 | 2.03B | +134.16% | 6.60B | 4.57B | 0.38 |
| Q2 FY2002 | 30 Jun 2002 | 1.12B | — | 4.67B | 3.54B | 0.50 |
| Q1 FY2002 | 31 Mar 2002 | 1.18B | — | 4.42B | 3.24B | 0.55 |
| Q4 FY2001 | 31 Dec 2001 | 1.13B | — | 4.48B | 3.35B | 0.55 |
| Q3 FY2001 | 30 Sept 2001 | 866.80M | — | 4.28B | 3.41B | 0.40 |
Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
Total debt counts commercial paper, term debt and lease liabilities.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet
Common questions about Elevance Health's debt
Source: Financial Modeling Prep